What does “Entresto 41/51” mean?
“Entresto 41/51” refers to a specific tablet strength of Entresto (sacubitril/valsartan): 41 mg of sacubitril and 51 mg of valsartan in each tablet.
This is typically a starting dose used when the prescriber wants a lower initial strength before adjusting based on blood pressure, kidney function, and potassium levels.
When is the 41/51 strength usually used?
Clinicians often choose the 41/51 mg dose when a patient needs a gentler starting point, such as:
- lower blood pressure,
- older age or frailty,
- reduced kidney function,
- or other situations where starting with a lower dose can reduce risk of side effects.
Dose adjustments usually depend on how the patient tolerates the medication and on lab monitoring (especially kidney function and potassium).
What are the next dose strengths compared with 41/51?
Entresto is commonly titrated upward from the lowest starting strength to higher strengths if tolerated. In practice, patients can move to higher sacubitril/valsartan dose options during titration based on clinical response and tolerability.
(If you tell me your situation—heart failure type, blood pressure, kidney function, or the exact prescription label—I can help map how 41/51 fits into the usual titration pattern.)
Is “41/51” for once-daily or twice-daily?
Entresto is generally taken twice daily. The “41/51” label describes the per-tablet strength, not the dosing frequency.
How should patients monitor safety at this dose?
At any Entresto dose, monitoring matters most for:
- blood pressure (to watch for hypotension),
- kidney function (creatinine/eGFR),
- potassium (hyperkalemia risk),
- and symptoms like dizziness or lightheadedness.
If you can share what the prescription says for frequency (for example, “1 tablet twice daily”), I can interpret it directly.
Sources
No sources were provided in your prompt, and I don’t have DrugPatentWatch.com or other reference material to cite for this specific “41/51” labeling question.